CEACAM3 Human

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant
Cat. No.
BT4773
Source
Escherichia Coli.
Synonyms
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3, Carcinoembryonic Antigen CGM1, CD66d Antigen , CD66D, CGM1, Carcinoembryonic Antigen Gene Family Member 1, Nonspecific Cross-Reacting Antigen, W264, W282, CEA, CEACAM3.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CEACAM3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 144 amino acids (35-155 a.a) and having a molecular mass of 15.5kDa.
CEACAM3 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3, also known as CEACAM3, belongs to the immunoglobulin superfamily. This family of genes encodes cell adhesion proteins, often overexpressed in tumor tissues compared to normal tissues. CEACAM3 plays a crucial role in pathogen clearance by the innate immune system. Additionally, CEACAM3 is responsible for activating RAC1 during pathogen phagocytosis.
Description
Recombinant Human CEACAM3, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 144 amino acids (35-155 a.a). It has a molecular weight of 15.5 kDa. The protein includes a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, sterile, and filtered solution.
Formulation
The CEACAM3 protein solution is provided at a concentration of 0.25 mg/ml. It is formulated in phosphate-buffered saline (pH 7.4) with 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product should be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 85.0% by SDS-PAGE analysis.
Synonyms
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3, Carcinoembryonic Antigen CGM1, CD66d Antigen , CD66D, CGM1, Carcinoembryonic Antigen Gene Family Member 1, Nonspecific Cross-Reacting Antigen, W264, W282, CEA, CEACAM3.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSKLTIESM PLSVAEGKEV LLLVHNLPQH LFGYSWYKGE RVDGNSLIVG YVIGTQQATP GAAYSGRETI YTNASLLIQN VTQNDIGFYT LQVIKSDLVN EEATGQFHVY QENAPGLPVG AVAG.

Product Science Overview

Structure and Function

CEACAM3 is a glycoprotein that is primarily expressed on the surface of granulocytes, a type of white blood cell. It plays a crucial role in the immune system by mediating the phagocytosis of bacteria. The protein consists of an extracellular domain, a single transmembrane region, and a cytoplasmic tail. The extracellular domain is responsible for binding to bacterial pathogens, while the cytoplasmic tail contains signaling motifs that activate the immune response.

Role in Immune Response

CEACAM3 is particularly important in the body’s defense against Gram-negative bacteria. It acts as a receptor for various bacterial adhesins, which are molecules that facilitate the attachment of bacteria to host cells. Upon binding to these adhesins, CEACAM3 triggers a series of intracellular signaling events that lead to the engulfment and destruction of the bacteria by granulocytes .

Clinical Significance

The recombinant form of CEACAM3 has been studied for its potential therapeutic applications. By blocking the interactions between bacterial pathogens and human epithelial cells, recombinant CEACAM3 can inhibit bacterial infections. This has significant implications for the treatment of diseases caused by mucosal pathogens, such as Moraxella catarrhalis .

Research and Development

Recent studies have focused on the development of recombinant polypeptides derived from CEACAM3. These polypeptides have shown promise in blocking bacterial interactions and enhancing the immune response. Additionally, antibodies against CEACAM3 have been developed to further inhibit bacterial infections .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.